ATM and cancer: If ATM-phosphorylated MDC1 does not require RNF8 to mediate cisplatin resistance, we anticipated that the depletion of RNF8 alone would not change the si-MDC1-induced cisplatin sensitivity in BIN1-deficient cancer cells.